IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v10y2019i1d10.1038_s41467-019-12888-x.html
   My bibliography  Save this article

Identification and characterization of Cardiac Glycosides as senolytic compounds

Author

Listed:
  • Francisco Triana-Martínez

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS)
    BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS))

  • Pilar Picallos-Rabina

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Sabela Da Silva-Álvarez

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Federico Pietrocola

    (The Barcelona Institute of Science and Technology (BIST))

  • Susana Llanos

    (DNA Replication Group, Spanish National Cancer Research Centre (CNIO))

  • Verónica Rodilla

    (Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC)

  • Enrica Soprano

    (Universidade de Santiago de Compostela)

  • Pablo Pedrosa

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Alba Ferreirós

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Marta Barradas

    (Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC)

  • Fernanda Hernández-González

    (The Barcelona Institute of Science and Technology (BIST)
    Instituto de Investigaciones Biomedicas August Pi i Sunyer (IDIBAPS))

  • Marta Lalinde

    (Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC)

  • Neus Prats

    (The Barcelona Institute of Science and Technology (BIST))

  • Cristina Bernadó

    (Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC)

  • Patricia González

    (Spanish National Cancer Research Centre (CNIO))

  • María Gómez

    (Spanish National Cancer Research Centre (CNIO))

  • Maria P. Ikonomopoulou

    (Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC)

  • Pablo J. Fernández-Marcos

    (Madrid Institute for Advanced Studies (IMDEA) in Food, CEI UAM+CSIC)

  • Tomás García-Caballero

    (Facultad de Medicina. USC. Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Pablo Pino

    (Universidade de Santiago de Compostela)

  • Joaquín Arribas

    (Vall d´Hebron Institute of Oncology (VHIO) and CIBERONC
    Catalan Institution for Research and Advanced Studies (ICREA))

  • Anxo Vidal

    (CiCLOn, Centro Singular de Investigación en Medicina Molecular y Enfermedades Crónicas (CIMUS), Universidade de Santiago de Compostela, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS))

  • Miguel González-Barcia

    (Servicio de Farmacia, Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

  • Manuel Serrano

    (The Barcelona Institute of Science and Technology (BIST)
    Catalan Institution for Research and Advanced Studies (ICREA))

  • María I. Loza

    (BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS))

  • Eduardo Domínguez

    (BioFarma, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS))

  • Manuel Collado

    (Health Research Institute of Santiago de Compostela (IDIS), Xerencia de Xestión Integrada de Santiago (XXIS/SERGAS))

Abstract

Compounds with specific cytotoxic activity in senescent cells, or senolytics, support the causal involvement of senescence in aging and offer therapeutic interventions. Here we report the identification of Cardiac Glycosides (CGs) as a family of compounds with senolytic activity. CGs, by targeting the Na+/K+ATPase pump, cause a disbalanced electrochemical gradient within the cell causing depolarization and acidification. Senescent cells present a slightly depolarized plasma membrane and higher concentrations of H+, making them more susceptible to the action of CGs. These vulnerabilities can be exploited for therapeutic purposes as evidenced by the in vivo eradication of tumors xenografted in mice after treatment with the combination of a senogenic and a senolytic drug. The senolytic effect of CGs is also effective in the elimination of senescence-induced lung fibrosis. This experimental approach allows the identification of compounds with senolytic activity that could potentially be used to develop effective treatments against age-related diseases.

Suggested Citation

  • Francisco Triana-Martínez & Pilar Picallos-Rabina & Sabela Da Silva-Álvarez & Federico Pietrocola & Susana Llanos & Verónica Rodilla & Enrica Soprano & Pablo Pedrosa & Alba Ferreirós & Marta Barradas , 2019. "Identification and characterization of Cardiac Glycosides as senolytic compounds," Nature Communications, Nature, vol. 10(1), pages 1-12, December.
    • Handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12888-x
    DOI: 10.1038/s41467-019-12888-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-019-12888-x
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-019-12888-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cox, Lynne S., 2022. "Therapeutic approaches to treat and prevent age-related diseases through understanding the underlying biological drivers of ageing," The Journal of the Economics of Ageing, Elsevier, vol. 23(C).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12888-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.